Neurocrine Corp (NBIX) - Cash Funds per Share

Neurocrine Corp - graphic logo of issuer NBIX

Cash per share demonstrates the liquidity of Neurocrine Biosciences (NBIX), where 7.27 is the current value of the metric. Neurocrine Biosciences (NBIX) dominates its niche thanks to Ingrezza, exercising significant pricing power. However, reliance on a single product necessitates increased R&D spending. This is essential to strengthen a highly specialized ecosystem that establishes benchmark therapies for nervous system disorders.

Neurocrine Biosciences (NBIX) Cash Funds per Share: for the period 07/04/2022 - 11/21/2026

Comprehensive metric breakdowns and analytics for Neurocrine (NBIX)

- market capitalization indicators:
- cash availability and cash flow indicators:
Summary company analysis:Neurocrine Biosciences
Manufactured product of Neurocrine Biosciences, Inc.

To minimize risks, it is essential for an investor to assess asset liquidity via the amount of cash per common share. The strong pricing power of Neurocrine Biosciences (NBIX) due to the monopoly position of Ingrezza strengthens the current cash per share, where growth in this metric confirms a financial cushion, while stagnation indicates inefficient capital allocation, determining the overall resilience of the business.

Key competitors

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash Funds per Share Regencell Bioscience Ltd (RGC)|Cash per Share axsome.com (AXSM)|Cash per Share ACAD (acadia-pharm.com)|XENE - Cash per Single Share|vikingtherapeutics.com - Cash per Share|Supernus Pharma (SUPN) - Cash per Single Share|CPRX: Cash per Share|Denali Therapeutics Inc. (DNLI) - Cash per Share|Cash Funds per Share Harmony Pharma|Cash Funds per Share BHVN|Cash per Single Share AMLX (Amylyx Pharmaceuticals, Inc.)|Cash per Single Share Trevi Corp TRVI|Cash Funds per Share praxismedicines.com PRAX|AVXL - Cash per Single Share|CeriBell EEG - Cash per Share|Cash on Hand per Share prothena.com|Alector Therapeutics (ALEC) - Cash Funds per Share|Annexon Biosciences Inc. - Amount of Cash per Share|OMER (Omeros Corp) - Cash per Share|Cash per Share neurogene.com|Cash per Share ACIU|VYGR - Cash on Hand per Share|Cash Funds per Share Neumora Therapeutics Inc NMRA|Cash Funds Calculated per Share Scilex Holding Co. (SCLX)|TVGN - Cash Funds per Share|Cash on Hand per Share alphacognition.com|CGTX (Cognition Therapeutics, Inc.) - Cash per Single Share|IKT: Cash Calculated per Single Share|Cash Funds per Share Cassava Sciences, Inc.|ASRT (assertiotx.com) - Cash Calculated per Single Share|Cash Funds per Share Coya (COYA)|VTGN - Cash on Hand per Share|Cash per Share OVID (Ovid Therapeutics)|Acumen Pharma (ABOS) - Cash on Hand per Share|cervomed.com - Cash per Share|Amount of Cash per Share ATHE (Alterity Therapeutics Limited)|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share